secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)
CIK:        0000315545
Form:       8-K
Filed at:   2023-04-17T23:59:59+00:00
Accession:  0001493152-23-012457
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Provectus adds social media channels for investor updates; discontinues email newsletter
--------------------------------------------------------------------------------

- Will use Substack, Twitter, and LinkedIn for material disclosures.
- Discontinuing its emailed newsletter 'Provectus News'.
- Investors encouraged to monitor social media in addition to press releases and SEC filings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/315545/000149315223012457/0001493152-23-012457-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/315545/000149315223012457/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-012457

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer